MAZE Competitors & Alternatives
Compare Maze Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MAZE
Main Stock$24.50
Tradestie Score
49
Market Cap
$1.13B
Analyst Upside
+157.1%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.60
|
$1.50B | 7.2 | 57 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$36.11
|
$1.50B | - | 56 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$12.86
|
$1.49B | - | 45 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$23.40
|
$1.43B | - | 50 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.03
|
$1.42B | - | 58 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.41
|
$1.35B | - | 57 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$35.18
|
$1.32B | - | 57 | Compare |
|
MPLT
MPLT
|
$26.50
|
$1.30B | - | 56 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$6.01
|
$1.29B | 89.1 | 52 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.03
|
$1.29B | - | 52 | Compare |
More MAZE Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry